PrecNA LLC
Provider of instruments and services for producing customized lipid nanoparticle (LNP) formulations. Technology emphasizes microfluidic continuous-flow production and cartridge-based microfluidic devices. Offers formulation and analytical services (including cold chain, particle size, dye encapsulation, and toxicity studies) for applications in nanopharmaceuticals, vaccines/genomics, veterinary, agricultural, and commercial drug manufacturing.
Industries
N/A
Services
Formulation Development
Development and optimization of lipid nanoparticle formulations for drug delivery applications.
Cold Chain Study
Stability testing and evaluation of storage/temperature requirements for nanoparticle formulations.
Size Study
Particle size measurement and characterization services for nanoparticle formulations.
Dye Study
Studies of dye encapsulation and labeling within nanoparticle formulations.
Toxicity Study
Preclinical toxicity testing of nanoparticle formulations to assess safety profiles.
Formulation Development
Development and optimization of lipid nanoparticle formulations for drug delivery applications.
Cold Chain Study
Stability testing and evaluation of storage/temperature requirements for nanoparticle formulations.
Size Study
Particle size measurement and characterization services for nanoparticle formulations.
Dye Study
Studies of dye encapsulation and labeling within nanoparticle formulations.
Toxicity Study
Preclinical toxicity testing of nanoparticle formulations to assess safety profiles.
Expertise Areas
- Lipid nanoparticle formulation
- Microfluidic continuous-flow manufacturing
- Cartridge-based microfluidic systems
- Nanopharmaceutical development
Key Technologies
- Lipid nanoparticles (LNPs)
- Microfluidic continuous-flow processes
- Cartridge-based microfluidic devices
- Particle size analysis